On October 9, 2025, among penny stocks,
& Digital, Inc. (NUAI) emerged as the top gainer with an 83.80% surge, while
Corp (VNTG) recorded the steepest decline, plummeting 81.25%.
Top GainersNew Era Energy & Digital, Inc. (NUAI) NUAI surged 83.80%, ranking first among penny stocks today, with an intraday high of $3.18 and closing at $2.83. The company operates in the Oil, Gas & Consumable Fuels sector. Significant progress reported on October 9 regarding its flagship AI data center project drove investor enthusiasm. This follows an October filing detailing strategic pivots and infrastructure plans linked to rising AI demand. Reports also indicated a Nasdaq compliance notice received on September 3.
Bluejay Diagnostics, Inc. (BJDX) Bluejay Diagnostics surged 75.40%, ranking as today’s second-biggest penny stock gainer, hitting an intraday high of $4.17 and closing at $3.28 in the Healthcare Equipment and Supplies sector. Reports indicate a recently secured $4.5 million private placement priced at-the-market and an expanded strategic collaboration with SanyoSeiko on Oct 9 to accelerate near-patient testing innovations drove investor optimism.
Epwk Holdings Ltd. (EPWK) EPWK Holdings Ltd. surged 53.33% today, ranking as the third-largest gainer in penny stocks, hitting an intraday high of $0.15 and closing at $0.12. The China-based software firm's volatility follows its completion of an $8 million public offering. Recent reports indicate the company priced the offering on October 7th, issuing units at $0.33 each, and subsequently closed the transaction on October 8th. The capital raise is expected to support research and business expansion initiatives.
JFU Soars on Robust Results Shares of 9F Inc. (JFU), operating in Financial Services, surged 52.20% today, ranking as the 4th largest gainer among penny stocks. The stock reached an intraday high of $4.70 before closing at $4.20. Recent news contributed to the rally, including strong first-half 2025 results showing a 6.5% revenue increase announced last week. Simultaneously, market observers noted the company is addressing a late May Nasdaq filing notification concerning its 2024 annual report and is formulating a compliance plan.
Baosheng Media Group Holdings Limited (BAOS) Baosheng Media Group Holdings Limited (BAOS) surged 46.83%, ranking fifth among penny stocks, with an intraday high of $5.21 and a close at $4.86. The media sector firm's rally follows October 8 news of investor optimism around its market-beating momentum and reports of intensified trading activity driving the stock upward.
Top DeclinersVantage Corp (VNTG) Vantage Corp (VNTG), operating in marine transportation, saw its stock plummet 81.25% to a close of $1.20, the day's largest decline among penny stocks. The shares touched an intraday low of $0.98. Reports indicate Vantage filed its delayed Fiscal Year 2025 Annual Report with regulators on October 9, which coincided with intensified selling pressure observed today following the disclosure of its financial results.
Vs Media Holdings Limited (VSME) Vs Media Holdings Limited (VSME) plummeted 38.10%, ranking as today's second-worst penny stock performer, with an intraday low of $1.21 and closing at $1.30 in the media sector. Recent news indicated subsequent closings of $1.1 million in public offerings on October 7, coupled with muted market response to growth initiatives outlined in the October 4 year-end business update, driving investor retreat.
Ccsc Technology International Holdings Limited (CCTG) CCTG stock plummeted 32.91% today, ranking as the third largest decline in the penny stock market, closing at $1.57 after hitting an intraday low of $0.88. The company operates in the Electronics Equipment, Instruments and Components sector. Investor concerns intensified following the company's October 2 announcement of financial results for the first six months of fiscal year 2025 ended September 30, 2024, coinciding with disclosure of pricing details for its completed $7.06 million public offering of units at $0.60 each.
GT Biopharma, Inc. (GTBP) GT Biopharma, Inc. (GTBP), operating in the pharmaceuticals sector, saw its stock plummet 30.46% today, the 4th largest decline among penny stocks. Shares reached an intraday low of $0.70 before closing at $0.75. Reports indicate the company provided an update on enrollment in its GTB-3650 Phase 1 trial for relapsed or refractory hematologic malignancies on October 8, while an October 6 report highlighted market growth in immunotherapy, coinciding with the steep price decline.
Kalaris Therapeutics, Inc. (KLRS) Kalaris Therapeutics (KLRS), a clinical-stage Biotechnology company focusing on retinal diseases, plunged 29.82%, ranking as the fifth-largest decliner among penny stocks today. The stock hit an intraday low of $4.34 before closing at $4.63. Market sources linked the sharp downturn to perceived investor disappointment with the Q2 2025 financial results reported recently. Concurrently, analysts noted heightened sensitivity towards the company's pipeline progress and upcoming clinical catalysts despite its ongoing Phase 1b/2 trial enrollment announcement near month-end.
Comments
No comments yet